ARSA and chronic obstructive pulmonary disease: Probably, the lack of statistically significant differences in the activity of AcP, ASA, and CTS D may be due to the stage of advancement of COPD (GOLD category A) or may be related to the potential increase in the levels of the inhibitors of those enzymes.